Cargando…

Seroepidemiologic Effects of Influenza A(H1N1)pdm09 in Australia, New Zealand, and Singapore

To estimate population attack rates of influenza A(H1N1)pdm2009 in the Southern Hemisphere during June–August 2009, we conducted several serologic studies. We pooled individual-level data from studies using hemagglutination inhibition assays performed in Australia, New Zealand, and Singapore. We det...

Descripción completa

Detalles Bibliográficos
Autores principales: Trauer, James M., Bandaranayake, Don, Booy, Robert, Chen, Mark I., Cretikos, Michelle, Dowse, Gary K., Dwyer, Dominic E., Greenberg, Michael E., Huang, Q. Sue, Khandaker, Gulam, Kok, Jen, Laurie, Karen L., Lee, Vernon J., McVernon, Jodie, Walter, Scott, Markey, Peter G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3557971/
https://www.ncbi.nlm.nih.gov/pubmed/23260059
http://dx.doi.org/10.3201/eid1901.111643
_version_ 1782257361083170816
author Trauer, James M.
Bandaranayake, Don
Booy, Robert
Chen, Mark I.
Cretikos, Michelle
Dowse, Gary K.
Dwyer, Dominic E.
Greenberg, Michael E.
Huang, Q. Sue
Khandaker, Gulam
Kok, Jen
Laurie, Karen L.
Lee, Vernon J.
McVernon, Jodie
Walter, Scott
Markey, Peter G.
author_facet Trauer, James M.
Bandaranayake, Don
Booy, Robert
Chen, Mark I.
Cretikos, Michelle
Dowse, Gary K.
Dwyer, Dominic E.
Greenberg, Michael E.
Huang, Q. Sue
Khandaker, Gulam
Kok, Jen
Laurie, Karen L.
Lee, Vernon J.
McVernon, Jodie
Walter, Scott
Markey, Peter G.
author_sort Trauer, James M.
collection PubMed
description To estimate population attack rates of influenza A(H1N1)pdm2009 in the Southern Hemisphere during June–August 2009, we conducted several serologic studies. We pooled individual-level data from studies using hemagglutination inhibition assays performed in Australia, New Zealand, and Singapore. We determined seropositive proportions (titer >40) for each study region by age-group and sex in pre- and postpandemic phases, as defined by jurisdictional notification data. After exclusions, the pooled database consisted of, 4,414 prepandemic assays and 7,715 postpandemic assays. In the prepandemic phase, older age groups showed greater seropositive proportions, with age-standardized, community-based proportions ranging from 3.5% in Singapore to 11.9% in New Zealand. In the postpandemic phase, seropositive proportions ranged from 17.5% in Singapore to 30.8% in New Zealand, with highest proportions seen in school-aged children. Pregnancy and residential care were associated with lower postpandemic seropositivity, whereas Aboriginal and Torres Strait Islander Australians and Pacific Peoples of New Zealand had greater postpandemic seropositivity.
format Online
Article
Text
id pubmed-3557971
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-35579712013-02-04 Seroepidemiologic Effects of Influenza A(H1N1)pdm09 in Australia, New Zealand, and Singapore Trauer, James M. Bandaranayake, Don Booy, Robert Chen, Mark I. Cretikos, Michelle Dowse, Gary K. Dwyer, Dominic E. Greenberg, Michael E. Huang, Q. Sue Khandaker, Gulam Kok, Jen Laurie, Karen L. Lee, Vernon J. McVernon, Jodie Walter, Scott Markey, Peter G. Emerg Infect Dis Research To estimate population attack rates of influenza A(H1N1)pdm2009 in the Southern Hemisphere during June–August 2009, we conducted several serologic studies. We pooled individual-level data from studies using hemagglutination inhibition assays performed in Australia, New Zealand, and Singapore. We determined seropositive proportions (titer >40) for each study region by age-group and sex in pre- and postpandemic phases, as defined by jurisdictional notification data. After exclusions, the pooled database consisted of, 4,414 prepandemic assays and 7,715 postpandemic assays. In the prepandemic phase, older age groups showed greater seropositive proportions, with age-standardized, community-based proportions ranging from 3.5% in Singapore to 11.9% in New Zealand. In the postpandemic phase, seropositive proportions ranged from 17.5% in Singapore to 30.8% in New Zealand, with highest proportions seen in school-aged children. Pregnancy and residential care were associated with lower postpandemic seropositivity, whereas Aboriginal and Torres Strait Islander Australians and Pacific Peoples of New Zealand had greater postpandemic seropositivity. Centers for Disease Control and Prevention 2013-01 /pmc/articles/PMC3557971/ /pubmed/23260059 http://dx.doi.org/10.3201/eid1901.111643 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Research
Trauer, James M.
Bandaranayake, Don
Booy, Robert
Chen, Mark I.
Cretikos, Michelle
Dowse, Gary K.
Dwyer, Dominic E.
Greenberg, Michael E.
Huang, Q. Sue
Khandaker, Gulam
Kok, Jen
Laurie, Karen L.
Lee, Vernon J.
McVernon, Jodie
Walter, Scott
Markey, Peter G.
Seroepidemiologic Effects of Influenza A(H1N1)pdm09 in Australia, New Zealand, and Singapore
title Seroepidemiologic Effects of Influenza A(H1N1)pdm09 in Australia, New Zealand, and Singapore
title_full Seroepidemiologic Effects of Influenza A(H1N1)pdm09 in Australia, New Zealand, and Singapore
title_fullStr Seroepidemiologic Effects of Influenza A(H1N1)pdm09 in Australia, New Zealand, and Singapore
title_full_unstemmed Seroepidemiologic Effects of Influenza A(H1N1)pdm09 in Australia, New Zealand, and Singapore
title_short Seroepidemiologic Effects of Influenza A(H1N1)pdm09 in Australia, New Zealand, and Singapore
title_sort seroepidemiologic effects of influenza a(h1n1)pdm09 in australia, new zealand, and singapore
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3557971/
https://www.ncbi.nlm.nih.gov/pubmed/23260059
http://dx.doi.org/10.3201/eid1901.111643
work_keys_str_mv AT trauerjamesm seroepidemiologiceffectsofinfluenzaah1n1pdm09inaustralianewzealandandsingapore
AT bandaranayakedon seroepidemiologiceffectsofinfluenzaah1n1pdm09inaustralianewzealandandsingapore
AT booyrobert seroepidemiologiceffectsofinfluenzaah1n1pdm09inaustralianewzealandandsingapore
AT chenmarki seroepidemiologiceffectsofinfluenzaah1n1pdm09inaustralianewzealandandsingapore
AT cretikosmichelle seroepidemiologiceffectsofinfluenzaah1n1pdm09inaustralianewzealandandsingapore
AT dowsegaryk seroepidemiologiceffectsofinfluenzaah1n1pdm09inaustralianewzealandandsingapore
AT dwyerdominice seroepidemiologiceffectsofinfluenzaah1n1pdm09inaustralianewzealandandsingapore
AT greenbergmichaele seroepidemiologiceffectsofinfluenzaah1n1pdm09inaustralianewzealandandsingapore
AT huangqsue seroepidemiologiceffectsofinfluenzaah1n1pdm09inaustralianewzealandandsingapore
AT khandakergulam seroepidemiologiceffectsofinfluenzaah1n1pdm09inaustralianewzealandandsingapore
AT kokjen seroepidemiologiceffectsofinfluenzaah1n1pdm09inaustralianewzealandandsingapore
AT lauriekarenl seroepidemiologiceffectsofinfluenzaah1n1pdm09inaustralianewzealandandsingapore
AT leevernonj seroepidemiologiceffectsofinfluenzaah1n1pdm09inaustralianewzealandandsingapore
AT mcvernonjodie seroepidemiologiceffectsofinfluenzaah1n1pdm09inaustralianewzealandandsingapore
AT walterscott seroepidemiologiceffectsofinfluenzaah1n1pdm09inaustralianewzealandandsingapore
AT markeypeterg seroepidemiologiceffectsofinfluenzaah1n1pdm09inaustralianewzealandandsingapore
AT seroepidemiologiceffectsofinfluenzaah1n1pdm09inaustralianewzealandandsingapore